Cite
MLA Citation
John J McNamara et al.. “Safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2–5 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study.” Lancet, vol. 7, no. 4, 2019, pp. 325–335. http://access.bl.uk/ark:/81055/vdc_100079601737.0x00000d